comparemela.com

Latest Breaking News On - Cardiff oncology company profile - Page 2 : comparemela.com

Cardiff Oncology, Inc. (NASDAQ:CRDF) Short Interest Down 24.6% in October

Cardiff Oncology, Inc. (NASDAQ:CRDF) Short Interest Down 24.6% in October
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

California
United-states
Blackrock
Cardiff-oncology-inc
Nasdaq
Renaissance-technologies
Cardiff-oncology-company-profile
Citigroup-inc
Vanguard-group-inc
Blackrock-inc
Cardiff-oncology

Short Interest in Cardiff Oncology, Inc. (NASDAQ:CRDF) Rises By 25.4%

Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 673,000 shares, a growth of 25.4% from the August 31st total of 536,500 shares. Based on an average daily trading volume, of 609,800 […]

Blackrock
California
United-states
Cardiff-oncology-company-profile
Citigroup-inc
Cardiff-oncology-inc
Renaissance-technologies
Vanguard-group-inc
Nasdaq
Blackrock-inc
Cardiff-oncology

Cardiff Oncology, Inc. (NASDAQ:CRDF) Short Interest Update

Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) saw a significant decline in short interest in August. As of August 31st, there was short interest totalling 536,500 shares, a decline of 19.5% from the August 15th total of 666,400 shares. Based on an average trading volume of 569,500 shares, the short-interest ratio is presently 0.9 […]

Denver
Colorado
United-states
California
Nasdaq
Cardiff-oncology-company-profile
Cardiff-oncology-inc
Denver-wealth-management-inc
Cardiff-oncology
Get-free-report
Oncology-stock-down

Cardiff Oncology (NASDAQ:CRDF) PT Lowered to $13.00 at HC Wainwright

Cardiff Oncology (NASDAQ:CRDF – Free Report) had its target price trimmed by HC Wainwright from $14.00 to $13.00 in a report issued on Tuesday morning, MarketBeat.com reports. The firm currently has a buy rating on the stock. Cardiff Oncology Price Performance Shares of NASDAQ:CRDF opened at $2.07 on Tuesday. The business’s fifty day moving average […]

California
United-states
Cardiff-oncology-company-profile
Capital-partners
Renaissance-technologies
Citigroup-inc
Nasdaq
Cardiff-oncology-inc
Cardiff-oncology
Free-report
Gate-manager

Cardiff Oncology, Inc. (NASDAQ:CRDF) Sees Large Drop in Short Interest

Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) was the target of a large decrease in short interest during the month of July. As of July 15th, there was short interest totalling 492,900 shares, a decrease of 8.2% from the June 30th total of 537,000 shares. Based on an average daily trading volume, of 149,600 […]

California
United-states
Denver
Colorado
Denver-wealth-management-inc
Cardiff-oncology-company-profile
Cardiff-oncology-inc
Nasdaq
Cardiff-oncology
Get-free-report
Wealth-management

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.